The latter showed, amongst others, the presence of typical EV-markers such as CD9, CD63, and CD81, as well as markers of the parental cell type such as CD19, CD20, and CD40, some of which we could confirm on EVs obtained from the CLL-patient plasma (Supplementary Figure S1A). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.